| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $207.5M | -4.2% |
| Cost of Revenue | $75.5M | -0.7% |
| Gross Profit | $132.1M | -6.1% |
| R&D Expense | $201.8M | +11.0% |
| SG&A Expense | $99.7M | +0.5% |
| Operating Income | -$209.3M | -17.9% |
| Pre-tax Income | -$185.7M | -532.7% |
| Income Tax | $1.4M | -35.8% |
| Net Income | -$187.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $147.3M | -5.1% |
| Short-term Investments | $204.8M | -33.4% |
| Accounts Receivable | $235.7M | +257.2% |
| Current Assets | $635.0M | +11.8% |
| Total Assets | $823.2M | +2.5% |
| Current Liabilities | $191.7M | +43.4% |
| Total Liabilities | $401.8M | +57.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$157.4M | -15.1% |
| Capital Expenditures | $7.3M | -45.5% |
| Investing Cash Flow | $148.8M | -22.9% |
| Financing Cash Flow | $10.1M | +11.9% |
| Free Cash Flow | -$164.7M | -9.7% |
| -559.5% |
| EPS (Basic) | -$2.57 | -550.9% |
| EPS (Diluted) | -$2.57 | -575.9% |
| Stockholders' Equity |
| $421.4M |
| -23.2% |